{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:00:57Z","timestamp":1762354857369,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:00:00Z","timestamp":1778284800000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007188","name":"Uniformed Services University of the Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Epidemiology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.annepidem.2025.04.016","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T18:30:18Z","timestamp":1746124218000},"page":"67-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Racial disparity in Non-Hodgkin Lymphoma: Parallel survival analysis with data from the DoD central cancer registry and SEER"],"prefix":"10.1016","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7840-2806","authenticated-orcid":false,"given":"Jie","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander A.","family":"Dew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig D.","family":"Shriver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangmin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annepidem.2025.04.016_bib1","unstructured":"American Cancer Society. Cancer Facts & Figures 2024. Atlanta: American Cancer Society; 2024: https:\/\/www.cancer.org\/cancer\/types\/multiple-myeloma\/about\/key-statistics.html. Accessed on February 22, 2024."},{"issue":"3","key":"10.1016\/j.annepidem.2025.04.016_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/ajh.27202","article-title":"The Lymphoma Epidemiology of Outcomes cohort study: design, baseline characteristics, and early outcomes","volume":"99","author":"Cerhan","year":"2024","journal-title":"Am J Hematol"},{"issue":"5","key":"10.1016\/j.annepidem.2025.04.016_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1586\/14737140.2015.1023712","article-title":"New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy","volume":"15","author":"Chihara","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"9","key":"10.1016\/j.annepidem.2025.04.016_bib4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.24086","article-title":"Non-Hodgkin lymphoma subtype distribution, geodemographic patterns, and survival in the US: a longitudinal analysis of the National Cancer Data Base from 1998 to 2011","volume":"90","author":"Al-Hamadani","year":"2015","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.annepidem.2025.04.016_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canep.2014.12.001","article-title":"Racial differences in three major NHL subtypes: descriptive epidemiology","volume":"39","author":"Li","year":"2015","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"10.1016\/j.annepidem.2025.04.016_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1055-9965.EPI-15-0921","article-title":"Contributions of subtypes of Non-Hodgkin Lymphoma to mortality trends","volume":"25","author":"Howlader","year":"2016","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.016_bib7","first-page":"393","article-title":"Improving outcomes for patients with diffuse large B-cell lymphoma","volume":"60","author":"Flowers","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/j.annepidem.2025.04.016_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.annepidem.2025.04.016_bib9","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clml.2011.03.012","article-title":"Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data","volume":"11","author":"Komrokji","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.016_bib10","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1002\/cam4.5551","article-title":"Chimeric antigen receptor T (CAR-T) cells: novel cell therapy for hematological malignancies","volume":"12","author":"Abbasi","year":"2023","journal-title":"Cancer Med"},{"issue":"11","key":"10.1016\/j.annepidem.2025.04.016_bib11","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1002\/cncr.25765","article-title":"Racial differences in the presentation and outcomes of diffuse large B-cell lymphoma in the United States","volume":"117","author":"Shenoy","year":"2011","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.016_bib12","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.clml.2011.07.002","article-title":"Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States","volume":"11","author":"Shenoy","year":"2011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.annepidem.2025.04.016_bib13","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1186\/1471-2407-10-625","article-title":"Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)","volume":"10","author":"Griffiths","year":"2010","journal-title":"BMC Cancer"},{"issue":"19","key":"10.1016\/j.annepidem.2025.04.016_bib14","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1002\/cncr.27513","article-title":"Racial differences in presentation and management of follicular non-Hodgkin lymphoma in the United States: report from the National LymphoCare Study","volume":"118","author":"Nabhan","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.annepidem.2025.04.016_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3109\/10428194.2012.708751","article-title":"Examining racial differences in diffuse large B-cell lymphoma presentation and survival","volume":"54","author":"Flowers","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.annepidem.2025.04.016_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clml.2015.06.005","article-title":"Persistent disparities among patients with T-cell non-hodgkin lymphomas and B-cell diffuse large cell lymphomas over 40 years: a SEER database review","volume":"15","author":"Crozier","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.016_bib17","article-title":"Racial disparities in survival among Non-Hodgkin Lymphoma patients: an analysis of the SEER database (2007-2015)","volume":"14","author":"Abodunrin","year":"2022","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.annepidem.2025.04.016_bib18","first-page":"1153","article-title":"US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma","volume":"26","author":"Kent","year":"2015","journal-title":"Cancer Causes Control"},{"issue":"12","key":"10.1016\/j.annepidem.2025.04.016_bib19","doi-asserted-by":"crossref","first-page":"e947","DOI":"10.1016\/S2352-3026(21)00303-3","article-title":"Racial and ethnic survival disparities in patients with haematological malignancies in the USA: time to stop ignoring the numbers","volume":"8","author":"Bhatnagar","year":"2021","journal-title":"Lancet Haematol"},{"issue":"15","key":"10.1016\/j.annepidem.2025.04.016_bib20","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/cncr.32866","article-title":"Genome-defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B-cell lymphoma","volume":"126","author":"Lee","year":"2020","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.annepidem.2025.04.016_bib21","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1002\/cncr.28233","article-title":"Racial differences in chronic lymphocytic leukemia. Digging deeper","volume":"119","author":"Flowers","year":"2013","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.annepidem.2025.04.016_bib22","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1002\/cncr.28030","article-title":"Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center","volume":"119","author":"Falchi","year":"2013","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.annepidem.2025.04.016_bib23","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/bloodadvances.2022008643","article-title":"Racial and socioeconomic disparities in CLL\/SLL: analysis of SEER data from 2006 to 2019","volume":"7","author":"Kittai","year":"2023","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.016_bib24","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/ajh.23708","article-title":"The impact of race, age, and sex in follicular lymphoma: a comprehensive SEER analysis across consecutive treatment eras","volume":"89","author":"Nabhan","year":"2014","journal-title":"Am J Hematol"},{"issue":"23","key":"10.1016\/j.annepidem.2025.04.016_bib25","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2013-07-517110","article-title":"Socioeconomic disparities in mortality after diffuse large B-cell lymphoma in the modern treatment era","volume":"123","author":"Tao","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.annepidem.2025.04.016_bib26","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/cncr.28549","article-title":"Insurance status is related to diffuse large B-cell lymphoma survival","volume":"120","author":"Han","year":"2014","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.annepidem.2025.04.016_bib27","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1634\/theoncologist.2014-0386","article-title":"Survival disparities by insurance type for patients aged 15-64 years with non-Hodgkin lymphoma","volume":"20","author":"Pulte","year":"2015","journal-title":"Oncologist"},{"issue":"11","key":"10.1016\/j.annepidem.2025.04.016_bib28","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1002\/cncr.23914","article-title":"Ethnic variations in diagnosis, treatment, socioeconomic status, and survival in a large population-based cohort of elderly patients with non-Hodgkin lymphoma","volume":"113","author":"Wang","year":"2008","journal-title":"Cancer"},{"issue":"20","key":"10.1016\/j.annepidem.2025.04.016_bib29","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1002\/cam4.4249","article-title":"Racial and ethnic differences in the utilization of autologous transplantation for lymphoma in the United States","volume":"10","author":"Vaughn","year":"2021","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.annepidem.2025.04.016_bib30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/1055-9965.EPI-12-0466","article-title":"Disparities in the early adoption of chemoimmunotherapy for diffuse large B-cell lymphoma in the United States","volume":"21","author":"Flowers","year":"2012","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.016_bib31","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1080\/10428194.2018.1546855","article-title":"Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase study","volume":"60","author":"Ritter","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"10.1016\/j.annepidem.2025.04.016_bib32","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.3109\/10428194.2014.898758","article-title":"The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era","volume":"55","author":"Nabhan","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"10.1016\/j.annepidem.2025.04.016_bib33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/10428194.2024.2338856","article-title":"The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA)","volume":"65","author":"Ta","year":"2024","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"10.1016\/j.annepidem.2025.04.016_bib34","first-page":"420","article-title":"Health disparity in use of novel agents for first-line therapy in Black and White patients with chronic lymphocytic leukemia in the Department of Veterans Affairs","volume":"29","author":"Lucero","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.016_bib36","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/1055-9965.EPI-13-0143","article-title":"Race and colon cancer survival in an equal-access health care system","volume":"22","author":"Andaya","year":"2013","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"10.1016\/j.annepidem.2025.04.016_bib37","first-page":"627","article-title":"Race and overall survival in men diagnosed with prostate cancer in the Department of Defense Military Health System, 1990-2010","volume":"30","author":"Alexander","year":"2019","journal-title":"Cancer Causes Control"},{"issue":"10","key":"10.1016\/j.annepidem.2025.04.016_bib38","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1158\/1055-9965.EPI-12-0560","article-title":"Lung cancer survival among black and white patients in an equal access health system","volume":"21","author":"Zheng","year":"2012","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.016_bib39","first-page":"1019","article-title":"Survival among Black and White patients with renal cell carcinoma in an equal-access health care system","volume":"26","author":"Lin","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.annepidem.2025.04.016_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canep.2016.04.012","article-title":"Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system","volume":"42","author":"Schinkel","year":"2016","journal-title":"Cancer Epidemiol"},{"issue":"3","key":"10.1016\/j.annepidem.2025.04.016_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1158\/1055-9965.EPI-23-0862","article-title":"Differences in Survival between Black and White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data from the DOD Central Cancer Registry and SEER","volume":"33","author":"Lin","year":"2024","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.annepidem.2025.04.016_bib42","unstructured":"National Cancer Institute. Surveillance, Epidemiology, and End Resuls Program. \u3008https:\/\/seer.cancer.gov\/\u3009 Accessed on April 4, 2023."},{"key":"10.1016\/j.annepidem.2025.04.016_bib43","first-page":"906","article-title":"Consolidation of Cancer Registry and Administrative Claims Data on Cancer Diagnosis and Treatment in the US Military Health System","volume":"4","author":"Eaglehouse","year":"2020","journal-title":"JCO Clin Cancer Inf"},{"key":"10.1016\/j.annepidem.2025.04.016_bib44","unstructured":"International Classification of Diseases for Oncology, 3rd Edition (ICD-O-3). World Health Organization. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/96612\/9789241548496_eng.pdf; Accessed on April 4, 2023."},{"key":"10.1016\/j.annepidem.2025.04.016_bib45","unstructured":"American Joint Committee on Cancer. AJCC Cancer Staging Manual, sixth Edition. Pages 16-75. Greene F.L., Page D.L., Flemming I.D., et al. (eds.) Chicago, IL: Springer; 2002."},{"issue":"7","key":"10.1016\/j.annepidem.2025.04.016_bib47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ajh.24374","article-title":"Analysis of racial variations in disease characteristics, treatment patterns, and outcomes of patients with chronic lymphocytic leukemia","volume":"91","author":"Nabhan","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.annepidem.2025.04.016_bib48","unstructured":"Evaluation of the TRICARE Program: Fiscal Year 2021 Report to Congress: https:\/\/www.health.mil\/Military-Health-Topics\/Access-Cost-Quality-and-Safety\/Health-Care-Program-Evaluation\/Annual-Evaluation-of-the-TRICARE-Program. Accessed on December 21, 2022."},{"key":"10.1016\/j.annepidem.2025.04.016_bib49","unstructured":"TRICARE Rates and Reimbursement: https:\/\/www.health.mil\/Military-Health-Topics\/Access-Cost-Quality-and-Safety\/TRICARE-Health-Plan\/Rates-and-Reimbursement. Accessed on December 20, 2022."}],"container-title":["Annals of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725000912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047279725000912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:56:12Z","timestamp":1762354572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047279725000912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S1047279725000912"],"URL":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.04.016","relation":{},"ISSN":["1047-2797"],"issn-type":[{"type":"print","value":"1047-2797"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial disparity in Non-Hodgkin Lymphoma: Parallel survival analysis with data from the DoD central cancer registry and SEER","name":"articletitle","label":"Article Title"},{"value":"Annals of Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annepidem.2025.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}